Article Details
Retrieved on: 2025-03-27 01:03:24
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Monoclonal antibodies targeting type 2 cytokines have transformed inflammatory skin disease treatment, enhancing symptom management and patient ...
Article found on: www.dermatologytimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here